Global Virtual Clinical Trials Market By Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, Infectious Diseases, Neurological Disorders, Respiratory Disorders, Oncological Disorders, and Others), By Clinical Trial Phase (Phase I, Phase II, Phase III, and Phase IV), By Company Size (SMEs and Large), By End-users (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Medical Device Industries, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Sep 2024
- Report ID: 128820
- Number of Pages: 331
- Format:
-
keyboard_arrow_up
-
-
- PRA Health Sciences
- Nova Scotia Health
- Oracle Corporation Company Profile
- Medidata
- LEO Innovation Lab
- Signant Health
- ICON, plc
- CRF Health
- Covance
- Clinical Ink
- settingsSettings
Our Clients
- 128820
- Sep 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
